Stage-specific outcomes of patients with Uterine leiomyosarcoma: A comparison of the international federation of gynecology and obstetrics and american joint committee on cancer staging systems Academic Article uri icon

Overview

MeSH Major

  • Leiomyosarcoma
  • Uterine Cervical Neoplasms

abstract

  • Estimates of stage-specific PFS and OS for uterine LMS were altered substantially when using the AJCC versus FIGO staging system. Adjuvant treatment strategies should be tested in patients at substantial risk for disease progression and death. Neither the FIGO nor AJCC staging system is ideal for identifying such patients, suggesting a need for a uterine LMS-specific staging system to better target patients for trials of adjuvant therapies.

publication date

  • April 20, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3646302

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.19.8366

PubMed ID

  • 19255317

Additional Document Info

start page

  • 2066

end page

  • 72

volume

  • 27

number

  • 12